This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: A Study of the Safety, Efficacy, and Tolerability of Switching From the Standard Delayed Release Preparation of Divalproex Sodium to the Extended Release Formulation in Patients With Schizophrenia, Journal of Clinical Psychopharmacology, June 2004, Wolters Kluwer Health,
DOI: 10.1097/01.jcp.0000125687.27961.64.
You can read the full text:
The following have contributed to this page
